Enzyme-nanoparticle conjugates for biomedical applications

Area of Science:

• Biotechnology
• Materials Science
• Pharmacology

Background:

• Enzymes offer high specificity and activity for therapeutic use but face challenges like poor stability, immunogenicity, and toxicity.
• Conventional low molecular weight drugs are more common clinically than enzyme-based therapeutics.
• Advances in nanoparticle synthesis and nanomaterials offer new possibilities for drug delivery systems.

Purpose of the Study:

• To review the application of nanoparticles as carriers for enzyme drugs.
• To discuss the advantages and limitations of nanoparticle-enzyme constructs.
• To highlight the potential for improving clinical applications of enzyme therapeutics.

Main Methods:

• Literature review of recent data on nanoparticle-based enzyme drug delivery.
• Analysis of studies reporting in vitro and in vivo performance of these systems.
• Discussion of challenges and future directions for clinical translation.

Main Results:

• Nanoparticle carriers can potentially mitigate issues such as poor enzyme stability and systemic toxicity.
• Preliminary in vitro and animal model studies show promising results for nanoparticle-enzyme drug systems.
• Several clinically important enzyme drugs have been investigated for nanoparticle delivery.

Conclusions:

• Nanoparticle drug delivery systems show potential for enhancing the clinical application of enzyme therapeutics.
• Overcoming limitations like immunogenicity and toxicity requires further investigation.
• Clinical trials and regulatory considerations are essential for the successful translation of these advanced delivery systems.